The cross-priming capacity and direct presentation potential of an autoantigen are separable and inversely related properties

Journal of Immunology

Volumn 193, Issue 7, 2014, Pages 3296-3307

  Wang, Jinguo ^a,b   Nanjundappa, Roopa Hebbandi ^a,b   Shameli, Afshin ^a,b   Clemente Casares, Xavier ^a,b   Yamanouchi, Jun ^a   Elliott, John F ^c,d   Slattery, Robyn ^e   Serra, Pau ^f   Santamaria, Pere ^a,b,f  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e MONASH UNIVERSITY   (Australia)

^f INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD11B ANTIGEN; ISLET SPECIFIC GLUCOSE 6 PHOSPHATASE CATALYTIC SUBUNIT RELATED PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG; G6PC2 PROTEIN, MOUSE; GLUCOSE 6 PHOSPHATASE; HLA ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGENICITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CONTROLLED STUDY; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; LYMPH NODE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PROTEIN DEGRADATION; ANIMAL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; NECROSIS; PATHOLOGY;

ANIMALS; ANTIGEN PRESENTATION; APOPTOSIS; AUTOANTIGENS; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; DENDRITIC CELLS; GLUCOSE-6-PHOSPHATASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; INSULIN-SECRETING CELLS; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; NECROSIS;

EID: 84907225588     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401001     Document Type: Article

References (47)

1. Lieberman, S. M., and T. P. DiLorenzo. 2 003. A comprehensive guide to antibody and T-cell responses in type 1 diabetes. Tissue Antigens 62: 359-377.
2. Tsai, S., A. Shameli, and P. Santamaria. 2008. CD8+ T cells in type 1 diabetes. Adv. Immunol. 100: 79-124.
3. Santamaria, P. 2010. The long and winding road to understanding and conquering type 1 diabetes. Immunity 32: 437-445.
4. Wong, F. S., J. Karttunen, C. Dumont, L. Wen, I. Visintin, I. M. Pilip, N. Shastri, E. G. Pamer, and C. A. Janeway, Jr. 1999. Identification of an MHC class Irestricted autoantigen in type 1 diabetes by screening an organ-specific cDNA librar y. Nat. Med. 5: 1026-1031.
5. Lieberman, S. M., T. Takaki, B. Han, P. Santamaria, D. V. Serreze, and T. P. DiLorenzo. 2004. Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase. J. Immunol. 173: 6727-6734.
6. Verdaguer, J., J. W. Yoon, B. Anderson, N. Averill, T. Utsugi, B. J. Park, and P. Santamaria. 1996. Acceleration of spontaneous diabetes in TCR-betatransgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains. J. Immunol. 157: 4726-4735.
7. Verdaguer, J., D. Schmidt, A. Amrani, B. Anderson, N. Averill, and P. Santamaria. 1997. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186: 1663-1676.
8. Anderson, B., B. J. Park, J. Verdaguer, A. Amrani, and P. Santamaria. 1999. Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 96: 9311-9316.
9. DiLorenzo, T., T. Graser, T. Ono, G. Christianson, H. Chapman, D. Roopenian, S. Nathenson, and D. Serreze. 1998. Major histocompatibility complex class Ires tricted T-cells are required for all but end stages of diabetes development and use a prevalent T cell receptor alpha chain gene rearrangement. Proc. Natl. Acad. Sci. USA 95: 12538-12543.
10. Lieberman, S. M., A. M. Evans, B. Han, T. Takaki, Y. Vinnitskaya, J. A. Caldwell, D. V. Serreze, J. Shabanowitz, D. F. Hunt, S. G. Nathenson, et al. 2003. Identification of the beta cell antigen targeted by a prevalent population o f pathogenic CD8+ T cells in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 100: 8384-8388.
11. Trudeau, J., C. Kelly-Smith, B. Verchere, D. Finegood, P. Santamaria, and R. Tan. 2003. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J. Clin. Invest. 111: 217-223.
12. Han, B., P. Serra, A. Amrani, J. Yamanouchi, A. F. Marée, L. Edelstein-Keshet, and P. Santamaria. 2005. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide. Nat. Med. 11: 645-652.
13. Martin, C. C., L. J. Bischof, B. Bergman, L. A. Hornbuckle, C. Hilliker, C. Frigeri, D. Wahl, C. A. Svitek, R. Wong, J. K. Goldman, et al. 2001. Cloning and characterization of the human and rat islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) genes. J. Biol. Chem. 276: 25197-25207.
14. Norbury, C. C., S. Basta, K. B. Donohue, D. C. Tscharke, M. F. Princiotta, P. Berglund, J. Gibbs, J. R. Bennink, and J. W. Yewdell. 2004. CD8+ T cell cross-priming via transfer of proteasome substrates. Science 304: 1318-1321.
15. Shen, L., and K. L. Rock. 2004. Cellular protein is the source of cross-priming antigen in vivo. Proc. Natl. Acad. Sci. USA 101: 3035-3040.
16. Wolkers, M. C., N. Brouwenstijn, A. H. Bakker, M. Toebes, and T. N. Schumacher. 2004. Antigen bias in T cell cross-priming. Science 304: 1314-1317.
17. Trudeau, J. D., J. P. Dutz, E. Arany, D. J. Hill, W. E. Fieldus, and D. T. Finegood. 2000. Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes? Diabetes 49: 1-7.
18. Wheatley, D. N. 1989. Protein turnover in relation to growth status and the cell cycle in cultured mammalian cells. Revis. Biol. Celular 21: 377-400.
19. Schubert, U., L. C. Antó n, J. Gibbs, C. C. Norbury, J. W. Yewdell, and J. R. Bennink. 2000. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404: 770-774.
20. Princiotta M.F.,D. Finzi,S.B. Qian,J. Gibbs,S. Schuchmann,F. Buttgereit,Bennink J.R.,J.W. Yewdell. 2003. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity. 18: 343-354.
21. Yewdell, J. W. 2011. DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. Trends Immunol. 32: 548-558.
22. Khadra, A., P. Santamaria, and L. Edelstein-Keshet. 2010. The pathogenicity of self-antigen decreases at high levels of autoantigenicity: a computational approach. Int. Immunol. 22: 571-582.
23. Mohan, J. F., M. G. Levisetti, B. Calderon, J. W. Herzog, S. J. Petzold, and E. R. Unanue. 2010. Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in auto immune diabetes. Nat. Immunol. 11: 350-354.
24. Mohan, J. F., B. Calderon, M. S. Anderson, and E. R. Unanue. 2013. Pathogenic CD4? T cells recognizing an unstable peptide of insulin are directly recr uited into islets bypassing local lymph nodes. J. Exp. Med. 210: 2403-2414.
25. Wang, J., S. Tsai, A. Shameli, J. Yamanouchi, G. Alkemade, and P. Santamaria. 2010. In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammation. Proc. Natl. Acad. Sci. USA 107: 9317-9322.
26. Hamilton-Williams, E. E., S. E. Palmer, B. Charlton, and R. M. Slattery. 2003. Beta cell MHC class I is a late requirement for diabetes. Proc. Natl. Acad. Sci. USA 100: 6688-6693.
27. Hamilton-Williams, E. E., D. V. Serreze, B. Charlton, E. A. Johnson, M. P. Marron, A. Mullbacher, and R. M. Slattery. 2001. Transgenic rescue implicates beta2-microglobulin as a diabetes susceptibility gene in nonobese diabetic (NOD) mice. Proc. Natl. Acad. Sci. USA 98: 11533-11538.
28. Tsai, S., P. Serra, X. Clemente-Casares, J. Yamanouchi, S. Thiessen, R. M. Slattery, J. F. Elliott, and P. Santamaria. 2013. Antidiabetogenic MHC class II promotes the differe ntiation of MHC-promiscuous autoreactive T cells into FOXP3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 110: 3471-3476.
29. Thorel, F., V. Né pote, I. Avril, K. Kohno, R. Desgraz, S. Chera, and P. L. Herrera. 2010. Conversion of adult pancreatic alpha-cells to beta-cells after extreme betacell loss. Nature 464: 1149-1154.
30. Hamaguchi, K., H. R. Gaskins, and E. H. Leiter. 1991. NIT-1 , a pancreatic betacell line established from a transgenic NOD/Lt mouse. Diabetes 40: 842-849.
31. Varshavsky, A. 1992. The N-end rule. Cell 69: 725-735.
32. Dolan, B. P., L. Li, C. A. Veltri, C. M. Ireland, J. R. Bennink, and J. W. Yewdell. 2011. Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance. J. Immunol. 186: 2065-2072.
33. Huang, L., J. M. Marvin, N. Tatsis, and L. C. Eisenlohr. 2011. Cutting Edge: Selective role of ubiquitin in MHC class I antigen presentation. J. Immunol. 186: 1904- 1908.
34. Gagnerault, M. C., J. J. Luan, C. Lotton, and F. Lepault. 2002. Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. J. Exp. Med. 196: 369-377.
35. Höglund, P., J. Mintern, C. Waltzinger, W. Heath, C. Benoist, and D. Mathis. 1999. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J. Exp. Med. 189: 331-339.
36. Zhang, Y., B. O'Brien, J. Trudeau, R. Tan, P. Santamaria, and J. P. Dutz. 2002. In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes. J. Immunol. 168: 1466-1472.
37. Yamanouchi, J., J. Verdaguer, B. Han, A. Amrani, P. Serra, and P. Santamaria. 2003. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens. J. Immunol. 171: 6900-6909.
38. Binder, R. J., and P. K. Srivastava. 2005. Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells. Nat. Immunol. 6: 593-599.
39. Callahan, M. K., M. Garg, and P. K. Srivastava. 2008. Heat-shock protein 90 associates with N-terminal extended pe ptides and is required for direct and indirect antigen presentation. Proc. Natl. Acad. Sci. USA 105: 1662-1667.
40. Yewdell, J. W., and S. M. Haeryfar. 2005. Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design. Annu. Rev. Immunol. 23: 651-682.
41. Dolan, B. P., K. D. Gibbs, Jr., and S. Ostrand-Rosenberg. 2006. Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells. J. Immunol. 177: 6018-6024.
42. Qu, C., V. A. Nguyen, M. Merad, and G. J. Randolph. 2009. MHC class I/peptide transfer between dendritic cells overcomes poor cross-presentation by monocytederived APCs that engulf dying cells. J. Immunol. 182: 3650-3659.
43. Wakim, L. M., and M. J. Bevan. 2011. Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection. Nature 471: 629-632.
44. Alkemade, G. M., X. Clemente-Casares, Z. Yu, B.-Y. Xu, J. Wang, S. Tsai, J. R. Wright, Jr., B. O. Roep, and P. Santamaria. 2013. Local auto antigen expression as essential gatekeeper of memory T-cell recruitment to islet grafts in diabetic hosts. Diabetes 62: 905-911.
45. Lennon, G. P., M. Bettini, A. R. Burton, E. Vincent, P. Y. Arnold, P. Santamaria, and D. A. Vignali. 2009. T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event. Immunity 31: 643-653.
46. Calderon, B., J. A. Carrero, M. J. Miller, and E. R. Unanue. 2011. Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans. Proc. Natl. Acad. Sci. USA 108: 1561-1566.
47. Burton, A. R., E. Vincent, P. Y. Arnold, G. P. Lennon, M. Smeltzer, C. S. Li, K. Haskins, J. Hutton, R. M. Tisch, E. E. Sercarz, et al. 2008. On the pathogenicity of autoantigen-specific T-cell receptors. Diabetes 57: 1321-133 0.